Home › Free Stock Grades › NERV
Minerva Neurosciences, Inc. (NERV) Stock Grade
NERV · Healthcare
B
Market Cap
$34.0M
P/E Ratio
—
Revenue Growth (YoY)
0.0%
Net Margin
0.0%
Return on Equity
208.5%
Dividend Yield
None
About Minerva Neurosciences, Inc.'s fundamentals
Minerva Neurosciences is a small-cap biotechnology company with a market capitalization of $34.0 million that reported no year-over-year revenue growth and posted a net loss in its latest annual statement, resulting in a 0.0% net margin. The company does not currently pay a dividend. The company's return on equity metric of 208.5% reflects significant equity volatility typical of unprofitable biotech firms with minimal equity bases rather than operational strength.